ESR1 and aneurysmal bone cyst: In ER and/or PR positive HER2-negative ABC patients, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations should be assessed [I-A] to consider the use of PIK3CA inhibitors [3].